Boehringer Ingelheim has announced positive phase 3 clinical trial data for its asthma drug, tiotropium Respimat. The UniTinA-asthmaTM trial programme found that tiotropium delivered once daily via ...

DelveInsight's Asthma Market Insights report includes a comprehensive understanding of current treatment practices, asthma ...

As per SNS Insider Research, the prefilled syringes market is projected to grow at a 12.51% CAGR through 2032, driven by biologics demand, patient safety, and innovative drug delivery solutions.Austin ...

A major new analysis involving more than 130million people has revealed that five types of commonly taken medications could raise the risk of dementia. Antipsychotics, some medications for high blood ...